1 |
TUBB3
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
2 |
TUBB3
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
3 |
TUBB3
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
4 |
TUBB3
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
5 |
TUBB3
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
6 |
TUBB3
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
7 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
8 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
9 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
10 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
11 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
12 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
13 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
14 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
15 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
16 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
17 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
18 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
19 |
MAPK14
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
20 |
MAPK14
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
21 |
TUBB
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
22 |
TUBB
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
23 |
TUBB
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
24 |
TUBB
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
25 |
TUBB
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
26 |
TUBB
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
27 |
TUBB8
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
28 |
TUBB8
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
29 |
TUBB8
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
30 |
TUBB8
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
31 |
TUBB8
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
32 |
TUBB8
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
33 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
34 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
35 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
36 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
37 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
38 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
39 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
40 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D06635
D06635
|
Rilonacept
| [4] 51 51, 106, 107, 266 |
41 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D09315
D09315
|
Canakinumab
| [10] 46 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 |
42 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D09911
D09911
|
Gevokizumab
| [4] 41 41, 50, 56, 269 |
43 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
44 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D08976
D08976
|
Pomalidomide
| [5] 28 28, 51, 85, 227, 331 |
45 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D09669
D09669
|
Siltuximab
| [2] 28 28, 331 |
46 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D10080
D10080
|
Sirukumab
| [2] 41 41, 46 |
47 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D12487
D12487
|
Olokizumab
| [2] 46 46, 96 |
48 |
NFKB1
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D01146
D01146
|
Iguratimod
| [5] 46 46, 51, 53, 271, 300 |
49 |
PIK3CA
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11011
D11011
|
Alpelisib
| [1] 138 138 |
50 |
PIK3CA
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
51 |
PIK3CB
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
52 |
PIK3CD
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
53 |
PIK3CD
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| [3] 35 35, 53, 61 |
54 |
TLR9
| [3] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Salmonella infection, Tuberculosis | D12275
D12275
|
Cobitolimod
| [1] 97 97 |
55 |
MAPK11
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
56 |
MAPK11
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
57 |
MAPK13
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
58 |
MAPK13
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
59 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
60 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
61 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
62 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
63 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D11675
D11675
|
Mirdametinib
| [1] 34 34 |
64 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
65 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
66 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
67 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
68 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D11675
D11675
|
Mirdametinib
| [1] 34 34 |
69 |
RAF1
| [9] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Tuberculosis | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
70 |
BCL2
| [6] Sphingolipid signaling pathway Sphingolipid signaling pathway, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Small cell lung cancer | D10679
D10679
|
Venetoclax
| [1] 28 28 |
71 |
RELA
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D12181
D12181
|
Edasalonexent
| [1] 113 113 |
72 |
MAPK12
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
73 |
MAPK12
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
74 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00742
D00742
|
Etanercept
| [16] 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
75 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00754
D00754
|
Thalidomide
| [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
76 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
77 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02597
D02597
|
Adalimumab
| [17] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
78 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02598
D02598
|
Infliximab
| [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
79 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D03441
D03441
|
Certolizumab pegol
| [8] 37 37, 46, 49, 96, 97, 107, 226, 271 |
80 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04358
D04358
|
Golimumab
| [8] 46 46, 56, 84, 96, 97, 107, 270, 271 |
81 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04687
D04687
|
Lenalidomide
| [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
82 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D05393
D05393
|
Pegsunercept
| [1] 46 46 |
83 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D08976
D08976
|
Pomalidomide
| [5] 28 28, 51, 85, 227, 331 |
84 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D09944
D09944
|
Ozoralizumab
| [1] 46 46 |
85 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
86 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
87 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
88 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
89 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
90 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
91 |
TUBB1
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
92 |
TUBB1
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
93 |
TUBB1
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
94 |
TUBB1
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
95 |
TUBB1
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
96 |
TUBB1
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
97 |
TUBB6
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
98 |
TUBB6
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
99 |
TUBB6
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
100 |
TUBB6
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
101 |
TUBB6
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
102 |
TUBB6
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
103 |
ROCK2
| [7] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Salmonella infection, Yersinia infection | D07941
D07941
|
Fasudil
| [4] 2 2, 5, 7, 51 |
104 |
ROCK2
| [7] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Salmonella infection, Yersinia infection | D11815
D11815
|
Belumosudil
| [2] 51 51, 85 |